• iCAD to Report Third Quarter 2022 Financial Results on November 10, 2022

    Source: Nasdaq GlobeNewswire / 27 Oct 2022 07:40:03   America/Chicago

    NASHUA, N.H., Oct. 27, 2022 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that it will release financial results for the third quarter ended September 30, 2022, after the market close, and host a conference call at 4:30 PM Eastern Time on November 10, 2022.

    Conference Call
    Thursday, November 10, 2022 at 4:30 PM ET
    Domestic: 888-506-0062
    International: 973-528-0011
    Conference ID: 393244
    Webcast: https://www.webcaster4.com/Webcast/Page/2879/46603
       

    About iCAD, Inc.
    Headquartered in Nashua, NH, iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. For more information, visit www.icadmed.com.

    Media Inquiries:
    Jessica Burns, iCAD
    +1-201-423-4492
    jburns@icadmed.com

    Investor Inquiries:
    iCAD Investor Relations
    ir@icadmed.com


    Primary Logo

Share on,